Advanced Proteome Therapeutics Corporation (TSE:APC.H)
TSXV:APC.H

Advanced Proteome Therapeutics (APC.H) Financial Statements

0 Followers

Advanced Proteome Therapeutics Financial Overview

Advanced Proteome Therapeutics's market cap is currently ―. The company's EPS TTM is C$-0.068; its P/E ratio is -0.15; Advanced Proteome Therapeutics is scheduled to report earnings on December 19, 2024, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
Apr 23Jan 23Oct 22Jul 22Apr 22
Income Statement-
Total Revenue---$ 0.00$ 0.00
Gross Profit-----
EBIT$ -1.50M$ -320.80K$ -245.62K$ -109.95K$ -502.23K
EBITDA$ -1.50M$ -318.40K$ -244.45K$ -108.79K$ -501.07K
Net Income Common Stockholders$ -1.48M$ -277.99K$ -209.71K$ -76.16K$ -467.85K
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 38.70K$ 292.46K$ 312.16K$ 544.43K$ 761.60K
Total Assets$ 62.75K$ 326.09K$ 399.05K$ 636.41K$ 855.08K
Total Debt$ 30.79K$ 388.55K$ 320.39K$ 331.77K$ 612.90K
Net Debt$ -7.92K$ 96.09K$ 8.22K$ -212.66K$ -148.70K
Total Liabilities$ 84.49K$ 1.46M$ 1.25M$ 1.49M$ 2.01M
Stockholders Equity$ -21.74K$ 357.59K$ 579.77K$ 1.07M$ 719.86K
Cash Flow-
Free Cash Flow$ -91.61K--$ -223.08K$ -215.35K
Operating Cash Flow$ -91.61K$ -372.80K$ -232.26K$ -223.08K$ -215.35K
Investing Cash Flow$ 135.48K$ -35.80K-$ -1.00$ 0.00
Financing Cash Flow$ 5.59K$ 100.79K-$ 5.91K$ 204.01K
Currency in USD

Advanced Proteome Therapeutics Earnings and Revenue History

Advanced Proteome Therapeutics Debt to Assets

Advanced Proteome Therapeutics Cash Flow

Advanced Proteome Therapeutics Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis